Greater Glasgow and Clyde Medicines
Key to symbols The medicine should be initiated by, or on the advice of a specialist, but is suitable for continuation by a GP The medicine should only be used and prescribed by a specialist Indicates the preferred choice within a class or group of medicines
The medicine should be initiated by, or on the advice of a specialist, but is suitable for continuation by a GP
The medicine should only be used and prescribed by a specialist
Indicates the preferred choice within a class or group of medicines
9. Nutrition and blood

9.2. Fluids and electrolytes

9.2.1. Oral preparations for fluid and electrolyte imbalance

9.2.1.1. Oral potassium

Preferred List
POTASSIUM CHLORIDE

Prescribing Notes:

A potassium-sparing diuretic and potassium supplements should not be used concomitantly because of the risk of hyperkalaemia.

BNF Link

Total Formulary
CALCIUM POLYSTYRENE SULPHONATE

Restrictions:

For use within the acute (hospital) sector only.

Prescribing Notes:

Please note, different preparations of calcium polystyrene sulphonate may require different dosing schedules.

BNF Link

Specialist Only
PATIROMER (VELTASSA)

Restrictions:

Restricted to specialist use in the emergency care setting for the treatment of acute, life-threatening hyperkalaemia alongside standard care.

BNF Link

Specialist and GP
PATIROMER (VELTASSA)

Restrictions:

Restricted to specialist initiation in patients with hyperkalaemia (serum potassium >6.0mmol/L) with chronic kidney disease (CKD) stage 3b to 5 and/or heart failure who would otherwise need to downtitrate or discontinue their renin-angiotensin-aldosterone system inhibitor (RAASi) therapy to maintain a clinically acceptable serum potassium level.

BNF Link

Specialist Only
SODIUM POLYSTYRENE SULFONATE (RESONIUM A)

Restrictions:

Restricted to specialist use only.

BNF Link

Specialist Only
SODIUM ZIRCONIUM CYCLOSILICATE (LOKELMA)

Restrictions:

Restricted to specialist use in the emergency care setting for the treatment of acute, life-threatening hyperkalaemia alongside standard care.

Prescribing Notes:

Please refer to section 7.5.3 for treatment of hyperkalaemia in chronic kidney disease.

BNF Link

Specialist and GP
SODIUM ZIRCONIUM CYCLOSILICATE (LOKELMA)

Restrictions:

Restricted to specialist initiation in patients with hyperkalaemia (serum potassium >6.0mmol/L) with chronic kidney disease (CKD) stage 3b to 5 and/or heart failure who would otherwise need to down-titrate or discontinue their renin-angiotensin-aldosterone system inhibitor (RAASi) therapy to maintain a clinically acceptable serum potassium level. 

BNF Link

9.2.1.2. Oral sodium and water

Preferred List
DIORALYTE

Prescribing Notes:

Oral rehydration salts.

BNF Link

Total Formulary
Specialist and GP
SODIUM BICARBONATE

Restrictions:

Restricted to specialist initiation.

Prescribing Notes:

Please note, expiry dates of licensed and unlicensed oral solutions can vary greatly.

BNF Link

Specialist and GP
SODIUM CHLORIDE

Restrictions:

Restricted to specialist initiation.

BNF Link

9.2.1.3. Oral bicarbonate

Total Formulary
Specialist and GP
SODIUM BICARBONATE

Restrictions:

Restricted to specialist initiation.

Prescribing Notes:

Please note, expiry dates of licensed and unlicensed oral solutions can vary greatly.

BNF Link

Specialist and GP
POTASSIUM CITRATE AND POTASSIUM HYDROXYCARBONATE (SIBNAYAL)

Restrictions:

Use for the treatment of distal renal tubular acidosis (dRTA) is restricted to specialist initiation.

Prescribing Notes:

Monitoring and review of treatment will remain with renal clinics.

BNF Link

9.2.2. Parenteral preparations for fluid and electrolyte imbalance

9.2.2.1. Electrolytes and water

9.2.2.2. Plasma and plasma substitutes

Total Formulary
Specialist and GP
GELOFUSINE

Restrictions:

Restricted to specialist initiation.

BNF Link